on 30 Jul 2019
Last Applicant/ Owned by
100 ENTRADA DR
LOS ALAMOS
NM
87544
Serial Number
88225561 filed on 11th Dec 2018
Registration Number
5819333 registered on 30th Jul 2019
Correspondent Address
David S. Kerr
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
Medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit pathogens directed to aquatic organism; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit pathogens directed to aquatic Read More
Medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit pathogens directed to aquatic organism; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit pathogens directed to aquatic organism grown in aquaculture; Research and development of biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit the expression of target genes in pathogens affecting to aquatic organisms; Research and development of biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit the expression of target genes in pathogens affecting to aquatic organisms grown in aquaculture; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit the expression of target genes in pathogens affecting to aquatic organisms; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit the expression of target genes in pathogens affecting to aquatic organisms grown in aquaculture; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit bacterial quorum-sensing Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit bacterial quorum-sensing; Research and development of new biological products for therapeutic use to prevent or treat aquatic diseases; Research and development of new biological products for therapeutic use to prevent or treat diseases affecting animals grown in aquaculture
04th Dec 2018
04th Dec 2018
No 88225561
No Service Mark
No 90115.00400
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
30th Jul 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
06th Jan 2021 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
09th Oct 2019 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
30th Jul 2019 | REGISTERED-PRINCIPAL REGISTER |
14th May 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
14th May 2019 | PUBLISHED FOR OPPOSITION |
24th Apr 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
10th Apr 2019 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
05th Apr 2019 | ASSIGNED TO LIE |
14th Mar 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |